AUSTIN, Texas, Feb. 23, 2024 /PRNewswire/ — Summit Hotel Properties, Inc. (NYSE: INN) (the “Company”) today announced that its 2024 Annual Meeting of Stockholders will be held Wednesday, May 22, 2024, beginning at 8:00 a.m. Central Time. The meeting will be held at the Hampton Inn &…
Month: February 2024
LyondellBasell Announces Quarterly Dividend
HOUSTON and LONDON, Feb. 23, 2024 /PRNewswire/ — LyondellBasell today announced it has declared a dividend of $1.25 per share, to be paid March 11, 2024, to shareholders of record on March 4, 2024, with an ex-dividend date of March 1, 2024. About LyondellBasell We are LyondellBasell…
United States Wedding Management Market Report 2024-2029: Market Forecast to Reach $7.69 Billion by 2029, Growing at a CAGR of 1.5%
DUBLIN, Feb. 23, 2024 /PRNewswire/ — The “US Wedding Management Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The US wedding management market was valued at $7.03 billion in 2023 and is expected to reach $7.69 billion by 2029, growing at…
Disaster Relief Non-profit All Hands and Hearts Launches Program in Western Ukraine for Internally Displaced People (IDPs)
UZHHOROD, Ukraine, Feb. 23, 2024 /PRNewswire/ — All Hands and Hearts (AHAH), a non-profit organization that provides community-inspired, volunteer-powered disaster relief to international communities, has launched a crisis relief program in Western Ukraine two years after Russia’s brutal…
Weekly Recap: 11 Press Releases You Might Have Missed
A roundup of the most newsworthy press releases from PR Newswire this week, including Capital One’s acquisition of Discover, a WcDonald’s debut and TIME’s 2024 Women of the Year. NEW YORK, Feb. 23, 2024 /PRNewswire/ — With thousands of press releases published each week, it can be…
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS
NEW YORK, Feb. 23, 2024 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it has submitted a Special Protocol Assessment (SPA) request to the U.S. Food and Drug…
Horizon Capital Closes its Ukraine Fund IV at $350m, $100m above Target
KYIV, Ukraine, Feb. 23, 2024 /PRNewswire/ — Horizon Capital, a leading U.S. private equity firm, is pleased to announce that its latest Ukraine-focused fund, Horizon Capital Growth Fund IV (“HCGF IV”, the “Fund”), has reached $350 million in commitments at its Final Closing held in Tokyo…
Global Disinfection Robots Market Report 2024: Analysis of Funding and Investments for Developing Disinfection Robots
DUBLIN, Feb. 23, 2024 /PRNewswire/ — The “Global Disinfection Robots Market – Outlook & Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. As the world grapples with hygiene and sanitation challenges, the disinfection robots sector emerges as a beacon of…
Rodenticides Market worth $7.7 billion by 2029 – Exclusive Report by MarketsandMarkets™
CHICAGO, Feb. 23, 2024 /PRNewswire/ — The Rodenticides Market is estimated at USD 5.8 billion in 2024 and is projected to reach USD 7.7 billion by 2029, at a CAGR of 5.9% from 2024 to 2029 according to a report published by MarketsandMarkets™. Download PDF Brochure:…
Horizon Capital Closes its Ukraine Fund IV at $350m, $100m above Target
KYIV, Ukraine, Feb. 23, 2024 /PRNewswire/ — Horizon Capital, a leading U.S. private equity firm, is pleased to announce that its latest Ukraine-focused fund, Horizon Capital Growth Fund IV (“HCGF IV”, the “Fund”), has reached $350 million in commitments at its Final Closing held in Tokyo…
